Treat atrial fibrillation AF to prevent stroke

pradaxaPRADAXA 150 mg twice daily provided an additional 35% risk reduction of stroke/systemic embolism vs warfarin

  • Superior reduction of ischemic and hemorrhagic stroke vs warfarin
  • Similar rate of major bleeds with PRADAXA vs warfarin
  • PRADAXA is the ONLY anticoagulant to demonstrate superior reduction of ischemic stroke vs warfarin
  • PRADAXA also demonstrated a lower rate of intracranial bleeding vs warfarin

Additional 35% risk reduction of stroke/systemic embolism vs warfarin. Protect the brain by reducing the risk of ischemic stroke.

Learn more at pradaxapro.com

Similar Posts